About this episode
Dr Matthew OConnor discusses the positive outcomes from phase one human trials of a drug targeting 7KC removal from arteries.
Dr Matthew OConnor describes recent positive news from phase one human trials of their drug that removes 7KC from the arteries
People in this episode
Guest: Dr Matthew Oconnor
Topics covered
- human trials
- drug development
- cardiovascular health
Keywords
- 7KC
- arteries
- phase one trials
Mentioned in this episode
Products: Cyclarity
More episodes of LongeCity interviews
- Introducing the Rejuvenation Science Institute · June 3, 2025 · 25 min
- Interview With James Strole · April 6, 2025 · 28 min
- Interview with Dave Pascoe · March 17, 2025 · 30 min
- Interview (Part 2) with Patrick Thuet · March 1, 2025 · 27 min
- Interview with Geordie Rose · February 1, 2025 · 36 min
- Interview with Patrick Thuet · December 27, 2024 · 31 min
Explore listener stats, chart rankings, contacts and more on the LongeCity interviews podcast page.